Aeterna Zentaris (AEZS) Posts Q4 Loss of $1.46/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/17/2026

1. SPY
2. EYPT
3. GNK
4. NVDA
5. PLUR
6. AZN
7. SPCX
8. FNGR
9. GSAT
10. S

Go back to Aeterna Zentaris (AEZS) Posts Q4 Loss of $1.46/Share

Aeterna Zentaris Reports Fourth Quarter and Full-Year 2015 Financial and Operating Results

March 29, 2016 5:00 PM EDT

Fourth quarter progress lays foundation for promising 2016

All amounts are in US Dollars

Fourth quarter key developments

Capital structure repaired Share consolidation successfully concluded Compliance with NASDAQ listing standards achieved $15.4 million of net capital obtained on favorable terms Product development advanced towards registration Zoptrex (zoptarelin doxorubicin) pivotal Phase 3 clinical program received DSMB recommendation to continue to completion following review of the final interim efficacy and safety data; completion of trial scheduled for Q3 2016... More